These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25944303)

  • 1. Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis.
    Rosso DA; Amaral D; Latella A; Chantada G; Braier JL
    Br J Haematol; 2016 Jan; 172(2):287-90. PubMed ID: 25944303
    [No Abstract]   [Full Text] [Related]  

  • 2. Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis.
    Abraham A; Alsultan A; Jeng M; Rodriguez-Galindo C; Campbell PK
    Pediatr Blood Cancer; 2013 Jun; 60(6):E19-22. PubMed ID: 23255383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Thrombocytopenia in a Child With Refractory Langerhans Cell Histiocytosis Following Cladribine Containing Therapy.
    Lai CY; Pettit T
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):620-623. PubMed ID: 29889804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
    Donadieu J; Bernard F; van Noesel M; Barkaoui M; Bardet O; Mura R; Arico M; Piguet C; Gandemer V; Armari Alla C; Clausen N; Jeziorski E; Lambilliote A; Weitzman S; Henter JI; Van Den Bos C;
    Blood; 2015 Sep; 126(12):1415-23. PubMed ID: 26194764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recurrent and Refractory Langerhans Cell Histiocytosis in Children Treated with the Combination of Cladribine and Cytarabine].
    DU Y; Xiong H; Li H; Li JX; Tao F; Yang L; Lu WJ; Qi SS; Zhang LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):943-949. PubMed ID: 35680831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerhans cell histiocytosis, a case of Letterer Siwe disease.
    Pant C; Madonia P; Bahna SL; Bass PF; Jeroudi M
    J La State Med Soc; 2009; 161(4):211-2. PubMed ID: 19785312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
    Wierzbowska A; Robak T; Pluta A; Wawrzyniak E; Cebula B; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S; Giebel S; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Kiełbiński M; Zawilska K; Kłoczko J; Wrzesień-Kuś A;
    Eur J Haematol; 2008 Feb; 80(2):115-26. PubMed ID: 18076637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
    Apollonsky N; Lipton JM
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Treatment of Refractory Langerhans Cell Histiocytosis of the Choroid Plexus in a Child With Pulse Dexamethasone and Lenalidomide.
    Uppuluri R; Ramachandrakurup S; Balaji R; Subburaj D; Bakane A; Raj R
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e74-e78. PubMed ID: 28099396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases.
    Adam Z; Szturz P; Vaníček J; Moulis M; Pour L; Krejčí M; Hájek R; Mayer J
    Acta Oncol; 2013 Jun; 52(5):994-1001. PubMed ID: 22937955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term complete response after treatment with cytarabine, vincristine, and prednisone in an infant with refractory multisystem Langerhans cell histiocytosis.
    Cook R; Berkow RL; Kelly DR; Friedman GK
    Pediatr Blood Cancer; 2011 Jul; 57(1):180-1. PubMed ID: 21412968
    [No Abstract]   [Full Text] [Related]  

  • 13. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.
    Bernard F; Thomas C; Bertrand Y; Munzer M; Landman Parker J; Ouache M; Colin VM; Perel Y; Chastagner P; Vermylen C; Donadieu J
    Eur J Cancer; 2005 Nov; 41(17):2682-9. PubMed ID: 16291085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis].
    Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kawaguchi H; Sakashita K; Yasui M; Koga Y; Kobayashi R; Ishii E; Fujimoto J; Horibe K; Bessho F; Tsunematsu Y; Imashuku S
    Int J Hematol; 2016 Jul; 104(1):99-109. PubMed ID: 27040279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with 2-chlorodeoxyadenosine of refractory pediatric Langerhans cell histiocytosis with initial involvement of the gastrointestinal tract.
    Mayumi A; Imamura T; Sakamoto K; Ota T; Osone S; Usami I; Hosoi H
    Int J Hematol; 2019 Dec; 110(6):756-762. PubMed ID: 31350665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of intermediate-dose cytarabine in the treatment of children with refractory high risk Langerhans cell histiocytosis].
    Wang WQ; Ge J; Ma HH; Lian HY; Cui L; Zhang L; Li ZG; Wang TY; Zhang R
    Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1118-1123. PubMed ID: 38018049
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine.
    Choi SW; Bangaru BS; Wu CD; Finlay JL
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):503-6. PubMed ID: 12794533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review].
    Yao X; Ying H; Weihong Z; Qing S; Xintian L
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of multiple relapsed-refractory Langerhans cell histiocytosis with cyclosporine.
    Özyörük D; Yozgat AK; Kaçar D; Yazal Erdem A; Işık M; Güzelküçük Z; Hacısalihoğlu Ş
    Tumori; 2021 Dec; 107(6):NP120-NP122. PubMed ID: 34423687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.